Get started
Author

Silvia Strumia

Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings
2016 · Simone Baiardi, Sabina Capellari, et al. · Journal of Alzheimer s Disease · 88
PDF
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Neurology Neuroimmunology & Neuroinflammation · 76
PDF
Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis
2021 · Damiano Baroncini, Marta Simone, et al. · JAMA Neurology · 63
PDF
Multiple Sclerosis Progression and Relapse Activity in Children
2023 · Pietro Iaffaldano, Emilio Portaccio, et al. · JAMA Neurology · 55
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power
2018 · Enrico Franceschi, Alicia Tosoni, et al. · World Neurosurgery · 51
PDF
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study
2023 · Piero Barbanti, Gabriella Egeo, et al. · The Journal of Headache and Pain · 48
PDF
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
2021 · Maria Pia Sormani, Irene Schiavetti, et al. · Multiple Sclerosis Journal · 47
Definitive childlessness in women with multiple sclerosis: a multicenter study
2017 · Diana Ferraro, Anna Maria Simone, et al. · Neurological Sciences · 45
PDF
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?
2014 · Alba A. Brandes, Enrico Franceschi, et al. · Neuro-Oncology Practice · 36
PDF
GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures
2025 · Piero Barbanti, Gabriella Egeo, et al. · The Journal of Headache and Pain · 27
PDF
Impact of COVID-19 pandemic on acute stroke care: facing an epidemiological paradox with a paradigm shift
2020 · Matteo Paolucci, Sara Biguzzi, et al. · Neurological Sciences · 23
PDF
Neurotoxicity of acyclovir and valacyclovir in a hemodialyzed patient
2003 · S. Strumia, P. De Mitri, et al. · European Journal of Neurology · 18
First-line disease-modifying drugs in relapsing–remitting multiple sclerosis: an Italian real-life multicenter study on persistence
2018 · Diana Ferraro, Valentina Camera, et al. · Current Medical Research and Opinion · 17
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
2023 · Paola Mosconi, Tommaso Guerra, et al. · Neurological Sciences · 14
PDF
The first report of the Italian Migraine Registry (I-GRAINE)
2022 · Piero Barbanti, Gabriella Egeo, et al. · Neurological Sciences · 14
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy
2021 · Elisa Baldin, Corrado Zenesini, et al. · Neuroepidemiology · 9
Long-term follow-up study of vigabatrin in the treatment of refractory epilepsy
1994 · Roberto Michelucci, Lucilla Veri, et al. · Journal of Epilepsy · 9
Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register
2022 · Roberto Bergamaschi, Ettore Beghi, et al. · Neurological Sciences · 5
PDF
Stroke pathway performance assessment: a retrospective observational study
2023 · Jacopo Camporesi, Silvia Strumia, et al. · BMC Health Services Research · 4
PDF
Endovascular thrombectomy in addition to intravenous thrombolysis versus intravenous thrombolysis alone in medium distal vessel occlusions: Results from the SITS International Stroke Treatment Register
2026 · Boris Keselman, Michael Mazya, et al. · International Journal of Stroke · 2
PDF
Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study
2026 · Piero Barbanti, Gabriella Egeo, et al. · The Journal of Headache and Pain · 1
Sars-CoV2 infection in pregnant women with multiple sclerosis
2023 · Maria Grazia Aprea, Irene Schiavetti, et al. · Multiple Sclerosis Journal · 1
PDF
Dimethyl fumarate‐induced lymphocyte count drop is related to clinical effectiveness in relapsing–remitting multiple sclerosis
2020 · E. Tsantes, E. Curti, et al. · European Journal of Neurology · 1
Effectiveness and safety of endovascular therapy compared to intravenous thrombolysis in acute ischaemic stroke due to medium-vessel occlusions: a real-world multicentre study from the Italian SITS registry
2026 · Matteo Farè, Elisa Bianchi, et al. · European Stroke Journal
PDF
Stroke Pathway impact on healthcare processes and outcomes: a retrospective observational study
2023 · A Di Pilla, J Camporesi, et al. · European Journal of Public Health
PDF
Works count: 28
Citation count: 654
H-index: 14
I10-index: 15
Year
Topic
Type